Condition
Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma clinical trials that are recruiting, in United States. By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1Country
Newest Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Epcoritamab for B-cell lymphoma patients not fully responding to CAR-T therapy | Phase 2 | Rochester, Minnesota and 5 other locations | Recruiting | Feb 2, 2024 |
| Combining three anti-cancer drugs for treating relapsed or refractory diffuse large B-cell lymphoma | Phase 1 | Duarte, California and 7 other locations | Recruiting | Aug 29, 2023 |
| Tegavivint treatment for patients with relapsed or refractory large B-cell lymphoma | Phase 1 | Columbus, Ohio | Recruiting | Mar 6, 2023 |
All recruiting trials (3)
-
Epcoritamab for B-cell lymphoma patients not fully responding to CAR-T therapy
This study is testing if a new treatment called epcoritamab can help people with B-cell lymphoma who didn't fully respond to CAR-T therapy feel better and improve their chances of survival.
-
Combining three anti-cancer drugs for treating relapsed or refractory diffuse large B-cell lymphoma
This study is testing a combination of three cancer drugs to see if they can help people with tough-to-treat diffuse large B-cell lymphoma feel better and respond to treatment.
-
Tegavivint treatment for patients with relapsed or refractory large B-cell lymphoma
This study is testing a new treatment called tegavivint to see if it can help people with relapsed or refractory large B-cell lymphoma feel better and how much of the drug is safe to use.
Related topics
Quick answers
How many Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.